National Institutes Of Health

Green Cross LabCell, a South Korea-based biopharmaceutical company, announced it will begin development of a COVID-19 treatment based on its anticancer therapy work using natural killer cells.

Cancer death rates declined between 2001 and 2017 in the United States for all cancer sites combined, according to the Annual Report to the Nation on the Status of Cancer published in Cancer.

A combined screening approach of systematic and MRI-targeted biopsy improved detection of all prostate cancers among men with MRI-visible lesions, according to results of a prospective study published in The New England Journal of Medicine.

Statin use was associated with improvement in Psoriasis Area and Severity Index score among patients with severe psoriasis, according to a recently published meta-analysis.

In 2014, there was an unexpected surge in the number of children in the United States who experienced sudden unexplained limb weakness and paralysis, particularly after a viral illness. The seemingly new condition, now recognized as acute flaccid myelitis, or AFM, is a subset of acute flaccid paralysis.

Myeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation may result in improved survival compared with reduced-intensity conditioning for patients with acute myeloid leukemia with genomic evidence of measurable residual disease, according to results of a randomized phase 3 study published in Journal of Clinical Oncology.

Black patients with cancer appeared to be at a higher risk for cancer-associated venous thromboembolism than patients of other races, according to results of a retrospective study published in American Journal of Clinical Oncology.

The release of the latest iteration of the Infectious Diseases Society of America guidelines on the management of influenza are a welcome addition that clinicians can employ to optimally diagnose and treat patients with influenza, an infectious disease that kills thousands of Americans annually. Of the myriad topics covered in the guidelines, one of the most important is antiviral treatments.

An FDA advisory committee today voted to support approval of pembrolizumab for the treatment of patients with bacillus Calmette-Guérin-unresponsive, high-risk, nonmuscle-invasive bladder cancer with carcinoma in-situ with or without papillary tumors who are ineligible for or have elected not to undergo cystectomy.

Women aged 50 years and older who had sustained weight loss over more than 8 years demonstrated a decreased risk for breast cancer compared with women whose weight remained stable, according to results of a pooled analysis published in Journal of the National Cancer Institute.